Related Experiment Video
Updated: Jun 16, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
[Cognitive-behavioural therapy for primary insomnia: effectiveness in a clinical setting]
L Van Houdenhove1, B Buyse, L Gabriels
1liesbet.vanhoudenhove@uzleuven.be
Cognitive behavioural therapy for insomnia (CBT-I) significantly improves sleep quality and reduces medication use in primary insomnia patients. This clinical study confirms CBT-I
Area of Science:
- Sleep Medicine
- Psychiatry
- Clinical Psychology
Background:
- Cognitive behavioural therapy for insomnia (CBT-I) effectiveness is established in RCTs for primary and comorbid insomnia.
- Clinical impact primarily affects sleep quality and medication use, with lesser effects on daytime functioning.
- Limited studies have assessed CBT-I effectiveness in real-world clinical settings.
Purpose of the Study:
- To evaluate the effectiveness of CBT-I for primary insomnia.
- To conduct an uncontrolled prospective study in a clinical tertiary care setting.
Main Methods:
- Included 76 primary insomnia patients referred to a sleep center.
- Administered a 6-week group-based CBT-I course.
- Assessed primary and secondary outcome measures.
Main Results:
- Significant improvements observed in sleep onset, sleep efficiency, and sleep quality.
- Total sleep time increase was less substantial due to sleep restriction guidelines.
- Significant improvements noted in dysfunctional cognitions, affective state, general health, and medication use.
Conclusions:
- CBT-I demonstrates significant positive impact on sleep quality in primary insomniacs.
- CBT-I effectively reduces medication use among primary insomnia patients.
- Daytime functioning is also positively influenced by CBT-I in a clinical tertiary care setting.
More Related Videos
04:33Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
CNS Depressants: Barbiturates and Benzodiazepines
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Blind Procedures